OKT3 for induction immunosuppression in renal transplantation: a comparative study of high versus low doses.
Norman
D J
DJ
Oregon Health Sciences University, Portland 97201.
Barry
J M
JM
Bennett
W M
WM
Munson
J L
JL
Meyer
M
M
Henell
K
K
Kimball
J
J
Hubert
B
B
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D017252:CD3 Complex; D003586:Cytomegalovirus Infections / Q000150:complications; D004306:Dose-Response Relationship, Immunologic; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000276:immunology / Q000379:methods*; D016853:Muromonab-CD3; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D012189:Retrospective Studies; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D017252:CD3 Complex; D016853:Muromonab-CD3; D011948:Receptors, Antigen, T-Cell